The research was funded by a grant from Genome Canada and Genome Quebec headed by Dr. Barry I. Posner, professor of Medicine at McGill University and the MUHC; and by a grant from the Canadian Foundation for Innovation to the Montreal Diabetes Research Centre, headed by Dr. Marc Prentki, professor of Medicine at the University of Montreal.
"In the last few years, advances in technology pioneered in Quebec, have made complex genetic analyses, such as those used in this study, possible," stated Genome Quebec President Paul LArchevque. "Without these advances an the collaboration between institutes, this research would not have been possible. The experimental approach used in this study, may help lead to the unraveling of other complex genetic diseases."
The Research Institute of the McGill University Health Centre (RI MUHC) is a world-renowned biomedical and health-care hospital research centre. Located in Montreal, Quebec, the institute is the research arm of the MUHC, a university health center affiliated with the Faculty of Medicine at McGill University. The institute supports over 500 researchers, nearly 1000 graduate and post-doctoral students and operates more than 300 laboratories devoted to a broad spectrum of fundamental and clinical research. The Research Institute operates at the forefront of knowledge, innovation and technology and is inextricably linked to the clinical programs of the MUHC, ensuring that patients benefit directly from the latest research-based knowledge. For further details visit: www.muhc.ca/research.
The McGill University Health Centre (MUHC) is a comprehensive academic health institution with an international reputation for excellence in clinical programs
'"/>
Contact: Christine Zeindler
christine.zeindler@muhc.mcgill.ca
514-843-1560
McGill University
19-Feb-2007